Current through September 25, 2024
Section 12 AAC 48.340 - Prescription and use of a pliarmaceutical agent or controlled substance(a) A licensee may not prescribe, order, or administer a phannaceutical agent, including a controlled substance, for the treatment of eye disease unless the use of the pharmaceutical agent or controlled substance is (1) within the scope of the licensee's education and training from an accredited school of optometry;(2) in compliance with 12 AAC 48.350 and this section; and(3) for the treatment of ocular disease or conditions, ocular adnexal disease or conditions, or emergency anaphylaxis.(b) A licensee may prescribe, order, or administer a controlled substance if the requirements of (a) of this section are met and (1) the controlled substance is not a schedule lA, IIA, or VIA controlled substance; however, a licensee may prescribe, order, or administer a pharmaceutical agent containing hydrocodone; (2) the licensee has filed with the department a current federal Drug Enforcement Administration number that is valid for the substance prescribed, ordered, or administered;(3) the licensee has registered with the prescription drug monitoring program (PDMP) controlled substance prescription database under AS 17.30.200 and 12 AAC 48.360; and(4) the licensee prescribes in accordance with AS 08.72.276.(c) In this section, "controlled substance" has the meaning given in AS 11.71.900.4/17/2019,Register 230, April 2019 Authority:AS 08.72.050
AS 08.72.140
AS 08.72.170
AS 08.72.272
AS 08.72.278